Field notes on clinical operations, AI governance, regulatory intelligence, and the work of building trials that validate themselves.
Responsible deployment demands auditability, traceability, and human-in-the-loop by design.
What recent guidance tells us about validating adaptive, AI-assisted early-phase designs.
Readiness scoring turns the TMF from a filing cabinet into a live quality instrument.
Why contradictory numbers survive all the way to submission — and how to catch them.
Treating the protocol as machine-readable infrastructure changes everything downstream.
Where people belong in an AI-assisted trial workflow, and how to encode it.
Beyond bolt-on tools: the operating model shift underway across the industry.
A practical reading of the framework for people who run studies, not models.
What to log, how to log it, and what inspectors will actually want to see.
White papers, case studies, and the Clinical Trial Standards Atlas™ — the reference layer behind the platform.
Deep-dive research on AI governance, evidence consistency, and readiness.
OpenOutcomes from teams who moved to continuous validation.
OpenA curated knowledge base for clinical-AI practitioners.
OpenGlobal clinical trial standards, mapped and kept current.
OpenWeekly clinical-AI and regulatory intelligence, written for decision-makers.